Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Larimar Therapeutics Inc

LRMR
Current price
7.74 USD -0.49 USD (-5.95%)
Last closed 8.23 USD
ISIN US5171251003
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 511 090 880 USD
Yield for 12 month +142.25 %
1Y
3Y
5Y
10Y
15Y
LRMR
21.11.2021 - 28.11.2021

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania. Address: Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

21.8 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-311 000 USD

Last Year

-272 000 USD

Current Quarter

-87 000 USD

Last Quarter

-80 000 USD

Key Figures LRMR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -65 510 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -23.59 %
PEG Ratio
Return On Equity TTM -37.48 %
Wall Street Target Price 21.8 USD
Revenue TTM
Book Value 3.31 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.12 USD
Diluted Eps TTM -1.12 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics LRMR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History LRMR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 29.05.2020
Dividend Date 29.05.2020

Stock Valuation LRMR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -4.1309
Price Book MRQ 2.4176

Financials LRMR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LRMR

For 52 weeks

2.18 USD 13.68 USD
50 Day MA 7.31 USD
Shares Short Prior Month 3 570 849
200 Day MA 7.88 USD
Short Ratio 4.53
Shares Short 3 712 928
Short Percent 8.91 %